Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012
- PMID: 23890130
- PMCID: PMC3830751
- DOI: 10.1016/j.pan.2013.05.002
Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012
Abstract
Description: Diabetes and glucose intolerance are common complications of chronic pancreatitis, yet clinical guidance on their detection, classification, and management is lacking.
Methods: A working group reviewed the medical problems, diagnostic methods, and treatment options for chronic pancreatitis-associated diabetes for a consensus meeting at PancreasFest 2012.
Results: Guidance Statement 1.1: Diabetes mellitus is common in chronic pancreatitis. While any patient with chronic pancreatitis should be monitored for development of diabetes, those with long-standing duration of disease, prior partial pancreatectomy, and early onset of calcific disease may be at higher risk. Those patients developing diabetes mellitus are likely to have co-existing pancreatic exocrine insufficiency. Guidance Statement 1.2: Diabetes occurring secondary to chronic pancreatitis should be recognized as pancreatogenic diabetes (type 3c diabetes). Guidance Statement 2.1: The initial evaluation should include fasting glucose and HbA1c. These tests should be repeated annually. Impairment in either fasting glucose or HbA1c requires further evaluation. Guidance Statement 2.2: Impairment in either fasting glucose or HbA1c should be further evaluated by a standard 75 g oral glucose tolerance test. Guidance Statement 2.3: An absent pancreatic polypeptide response to mixed-nutrient ingestion is a specific indicator of type 3c diabetes. Guidance Statement 2.4: Assessment of pancreatic endocrine reserve, and importantly that of functional beta-cell mass, should be performed as part of the evaluation and follow-up for total pancreatectomy with islet autotransplantation (TPIAT). Guidance Statement 3: Patients with pancreatic diabetes shall be treated with specifically tailored medical nutrition and pharmacologic therapies.
Conclusions: Physicians should evaluate and treat glucose intolerance in patients with pancreatitis.
Keywords: Chronic pancreatitis; Diabetes mellitus; GLP-1; Glucose tolerance test; Incretin; Insulin; Pancreatic polypeptide; Pancreatogenic diabetes.
Copyright © 2013 IAP and EPC. All rights reserved.
Conflict of interest statement
References
-
- Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology : official journal of the International Association of Pancreatology. 2011;11(3):279–94. - PubMed
-
- Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c) - Are we neglecting an important disease? European journal of internal medicine. 2013 Apr;24(3):203–6. - PubMed
-
- Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) Diabetes/metabolism research and reviews. 2012 May;28(4):338–42. - PubMed
-
- Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical